Seed VC · UK
To maximise value and transform patient outcomes by actively managing a strategic portfolio of life science companies diversified across different stages of the development cycle, delivering key value inflection points with the potential to deliver significant NAV growth through M&A and liquidity events.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers, Patients
Geography
UK, Europe, US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Syncona writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Syncona alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Syncona is one of them — and we'll tell you exactly where they sit in your top 100.